Nipro Medical Device Company Intelligence Report
| Publication Date | November 2008 |
|---|---|
| Publisher | Espicom |
| Product Type | Report |
| Pages | 18 |
| ISBN Number | not applicable |
| Product Code | ESP00194 |
Buy this product or for assistance call +44 20 7060 7474
Summary
Nipro Corporation, based in Osaka, Japan, was established in July 1954 and is engaged in the manufacture and marketing of medical devices, pharmaceuticals, glass and materials. The company also operated supermarkets and consumer drug stores in Japan through its Supermarket division, but sold these operations in June 2006.
The company's core medical device activities, including dialysis devices, intervention anaesthesiology devices, infusion and diagnostics products, and cardiopulmonary products, are undertaken by its Medical Equipment division, which is Nipro's largest unit, accounting for 64% of the company's total revenue in fiscal 2007 (ended 31st March 2008). Its Pharmaceutical division produces and sells generic drugs and in May 2007 expanded its activities to the production of percutaneously absorbed drugs through contract manufacturing. The Pharmaceutical division, which represented 28% of total sales in fiscal 2007, and Nipro's other activities are not covered in detail in this profile.
Nipro's Medical Equipment division operates main factories in Japan (Gunma and Akita), China (Shanghai), Thailand (Ayuthaya), the US (Florida) and Brazil (So Paulo). The division also has more than 30 sales offices in Europe, Asia and the Americas.
Content
- Overview
- Recent Key Events
- Financial Review
- Latest Results - First Half Fiscal 2008
- Nipro - First Half Fiscal 2008 Results ( million)
- Fiscal 2007
- Nipro Annual Revenues and Operating Income by Business Group, Fiscal 2007-2008
- Nipro Annual Revenues by Business Group, 2004-2008 ( million)
- Medical Equipment Division Annual Revenues and Operating Income, 2004-2008 ( million)
- Outlook
- Five-Year Financial Summary
- Financial Indicators
- Employees
- Latest Results - First Half Fiscal 2008
- Strategic Focus
- Product Portfolio
- Nipro - Product Summary
- Research and Development
- research Agreements
- Oxygenix and Japanese Universities
- research Agreements
- Manufacturing
- Japan
- US
- Brazil
- China
- Thailand
- Nipro - Medical Equipment Manufacturing Facilities
- Agreements
- B Braun Melsungen
- Nipro - Pre-2007 Agreements
- B Braun Melsungen
- Mergers and Acquisitions
- BioCorp SA
- Nipro Pre-2007 Medical Equipment Mergers and Acquisitions
- BioCorp SA
- Divestitures
- Nissho Corporation
- Key Corporate Events
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories











